The Number of Americans Skipping Scripts Jumped Between 2023 and 2025, KFF Poll Finds

And three more medicines -- Novartis’ Mayzent, Rydapt, and Tabrecta -- have been added to TrumpRx

Brian Reid

Mar 13, 2026